Araclon Biotech S.L.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD (NCT03461276) | Araclon Biotech S.L. | 2017-12-13 |
| Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients (NCT03113812) | Araclon Biotech S.L. | 2014-01-01 |
Track Araclon Biotech S.L. automatically
Every clearance here is in the API, with alerts when new ones post.